Barclays Maintains Overweight on JBS, Lowers Price Target to $21

Benzinga Newsdesk www.benzinga.com Negative 84.0%

Neg 84% Neu 0% Pos 0%

Barclays analyst Benjamin Theurer maintains JBS (NYSE:JBS) with a Overweight and lowers the price target from $23 to $21.